CoChat
Sign Up
Cited by 336Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 318 of the 318 references it cites were found in a registry or an index.

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Writing Committee Members, Ommen, Steve R., Mital, Seema, Burke, Michael A., Day, Sharlene M., Deswal, Anita, Elliott, Perry, Evanovich, Lauren L., Hung, Judy, Joglar, José A., Kantor, Paul, Kimmelstiel, Carey, Kittleson, Michelle, Link, Mark S., Maron, Martin S., Martinez, Matthew W., Miyake, Christina Y., Schaff, Hartzell V., Semsarian, Christopher, Sorajja, Paul·2020·Circulation
DOI 10.1161/cir.0000000000000938
Open this paper in CoChat — free account

Abstract

Aim: This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Structure: Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.

Overview

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000000938

Cites

318 of 318 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 317 references

Research works printed but not linked: 1

  1. 10.1161/jaha.116.005152 · DOI

Cited by

Sorted by citations

Items 301–336 of 336

Related

See all

Metadata

Authors
Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., Kimmelstiel, C., Kittleson, M., Link, M. S., Maron, M. S., Martinez, M. W., Miyake, C. Y., Schaff, H. V., Semsarian, C., & Sorajja, P.
Affiliations
  • ACC/AHA Representative.
  • American Hospital Association (US)
  • ASE Representative.
  • HRS Representative.
  • SCMR Representative.
  • AATS Representative.
  • SCAI Representative.
ORCID
Venue
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2020-12-22
Volume
142
Issue
25
Pages
e533-e557
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
DOI
10.1161/cir.0000000000000938
OpenAlex
W3113392623
Cited by
336
References
317
Citations by year
2026: 38 · 2025: 46 · 2024: 64 · 2023: 77 · 2022: 70 · 2021: 39 · 2020: 1
FWCI
30.28
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords
hypertrophic cardiomyopathy, diagnosis, treatment, guideline-directed medical therapy, risk stratification, genetic screening, family screening, lifestyle modification, surgical treatment, interventional catheterization, medication, pediatric patients, adult patients
MeSH terms
Algorithms, American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Decision Support Techniques, Humans, Predictive Value of Tests, United States, Treatment Outcome, Evidence-Based Medicine, Consensus, Cardiac Imaging Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review